Full Breakdown
White House Pushes New Federal Grant Rules to Prioritize Presidential Priorities
6/2/2026, 11:37:54 PM
OMB Proposes Sweeping Rewrite of Federal Grant Regulations
The Office of Management and Budget (OMB) released a 412-page draft rule on June 2, 2026, revising 2 CFR 200 for the second time in two years. The proposal would require senior political appointees to conduct a pre-issuance review of every discretionary grant and to certify that each award “demonstrably advances the president’s policy priorities.” It also expands termination authority, allowing agencies to cancel grants at any time if they are deemed contrary to the “public interest” or agency priorities.
Background & Context
President Donald Trump issued an August executive order, “Improving Oversight of Federal Grantmaking,” which called for tighter control over grantmaking and criticized “woke” diversity, equity and inclusion (DEI) initiatives. The 2024 rewrite of the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards focused on plain-language applications and access for underserved communities. The current draft builds on that framework while adding political vetting and ideological restrictions.
Key Figures & Groups
- Russell Vought, OMB Director and architect of the proposal.
- Dan Ramish, attorney with Haynes Boone, who commented on the pre-issuance review.
- Brette Fishman, director of grants-management solutions for FI Consulting and former deputy assistant secretary for grants at the Education Department.
- Federal agencies such as the National Institutes of Health (NIH) and the National Science Foundation (NSF) that administer research grants.
- Advocacy groups including the Union of Concerned Scientists and Stand Up for Science.
Data & Statistics
- The draft rule spans more than 400 pages.
- NIH has terminated about 2,300 active research grants, withdrawing $2.45 billion, and halted 160 clinical trials in cancer, HIV/AIDS, and chronic-disease research.
- In the first half of 2026, NIH published only 14 new funding opportunity announcements, compared with 756 in all of 2024.
- Public comments are due by July 13, 2026, giving a 45-day window.
Why It Matters / Impact
If finalized, the rule would shift grant decisions from peer-review panels to political appointees, potentially barring funding for projects that “deny the biological reality of sex,” support “anti-American values,” or engage in DEI and voter-registration activities. The changes could affect health, housing, science, transportation, and university research, altering the United States’ capacity for basic science and long-term innovation.
Official Statements & Responses
OMB stated the revisions aim to “ensure basic American principles of equality and equal opportunity are upheld throughout all stages of the award-making process” and to “reduce recipient burden.” The agency also noted that senior appointees must conduct pre-issuance reviews to guarantee “policy alignment.” OMB emphasized that the rule clarifies regulatory status and provides a process for future updates.
Criticism & Opposition
Scientists and policy analysts argue the proposal replaces expert peer review with political loyalty tests, threatens academic freedom, and could “silence research that is politically inconvenient.” Advocacy groups warn that the expanded termination provisions shift from remedial actions to penalties, undermining the historic commitment to support grant recipients.
Conflicting Reports & Gaps
Sources differ on the extent of termination-authority expansion: some describe it as a “new effort to expand termination rights,” while others note that termination provisions have been adjusted under both Trump and Biden administrations without specifying precise legal thresholds. The rule’s impact on indirect-cost rates remains unclear.
Verbatim Quotes
- “The revisions also aim to ensure that basic American principles of equality and equal opportunity are upheld throughout all stages of the award making process and that unlawful discrimination is no longer permitted.” — OMB
- “By calling for a pre-issuance review, there may be some concern about the involvement of senior appointees, but every administration has ways of influencing awards.” — Dan Ramish, attorney, Haynes Boone
- “It replaces expertise with political appointees, globally decouples the U.S. and completely guts our scientific ecosystem.” — Colette Delawalla, founder, Stand Up for Science
- “The new rules would allow for grant “termination based on the discretion of the Federal agency,” according to the proposal.” — Jules Barbati-Dajches, Center for Science and Democracy, Union of Concerned Scientists
What’s Next
Comments close on July 13, after which OMB may issue a final rule. Congressional committees and courts have previously challenged similar grant-control measures, suggesting potential legislative or judicial review. Stakeholders—including universities, research institutes, and industry groups—are expected to intensify lobbying and public-comment efforts.
